medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2011, Número 1

<< Anterior

Ann Hepatol 2011; 10 (1)


Biliverdin and Heme Oxygenase Antiviral Activity Against Hepatitis C Virus

Gutiérrez-Grobe Y, Vitek L, Tiribelli C, Kobashi-Margáin RA, Uribe M, Méndez-Sánchez N

Idioma: Ingles.
Referencias bibliográficas: 16
Paginas: 105-107
Archivo PDF: 34.81 Kb.


FRAGMENTO

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Zhu Z, Wilson AT, Luxon BA, Brown KE, Mathahs MM, Bandyopadhyay S, et al. Biliverdin Inhibits Hepatitis C Virus Nonstructural 3/4A Protease Activity: Mechanism for the Antiviral Effects of Heme Oxygenase? Hepatology 2010; 52: 1897-1905.

  2. Zhu Z, Wilson AT, Mathans MM, Wen F, Brown KE, Luxon BA et al. Heme oxygenase-1 supresses hepatitis C rivus replication and increases resistance of hepatocytes to oxidant injury. Hepatology 2008; 48: 1430-1439.

  3. Dionisio N, Garcia-Mediavilla MV, Sanchez-Campos S, Majano PL, Benedicto I, Rosado JA, et al. Hepatitis c virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes. J Hepatol 2009; 50:872-882.

  4. Vijayan V, Mueller S, Baumgart-Vogt E, Immenschuh S. Heme oxygenase-1 as a therapeutic target in inflammatory disorders of the gastrointestinal tract. World J Gastroenterol 2010; 16(25): 3112-3119.

  5. Shimizu H, Takahashi T, Suzuki T, Yamasaki A, Fujiwara T, Odaka Y, et al. Protective effect of heme oxygenase induction in ischemic acute renal failure. Crit Care Med 2000; 28: 809-817.

  6. Aztatzi-Santillán E, Nares-López FE, Márquez-Valadez B, Aguilera P, Chánez-Cárdenas ME.The Protective Role of Heme Oxygenase-1 in Cerebral Ischemia. Cent Nerv Syst Agents Med Chem 2010; 2010; 10(4): 310-6.

  7. Öllinger R, Pratschke J.Role of heme oxygenase-1 in transplantation. Transpl Int. 2010; 23(11): 1071-81.

  8. Sass G, Soares MC, Yamashita K, Seyfried S, Zimmermann WH, Eschenhagen T, et al. Heme oxygenase-1 and its reaction product, carbon monoxide, prevent inflammation-related apoptotic liver damage in mice. Hepatology 2003; 38: 909-918.

  9. Protzer U, Seyfried S, Quasdorff M, Sass G, Svorcova M, Webb D, Bohne F, et al. Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection. Gastroenterology 2007; 133: 1156- 1165.

  10. McPhee F, Caldera PS, Bemis GW, McDonagh AF, Kuntz ID, Craik CS. Bile Pigmentes as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro. Biochem J. 1996; 320: 681-686.

  11. Vitek L, Schwertner HA. The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv Clin Chem 2007; 43: 1-57.

  12. Qin XF. Inactivation of digestive proteases by deconjugated bilirubin: the possible evolutionary driving force for bilirubin or biliverdin predominance in animals. Gut 2007; 56: 1641-1642.

  13. Ascenzi P, Fasano M. Heme-hemopexin: a “chronosteric” heme-protein. IUMB Life 2007; 59: 700-708.

  14. Miller YI, Shaklai N. Kinetics of hemin distribution in plasma reveals its role in lipoprotein oxidation. Bioch Biophys Acta 1999; 1454: 153-164.

  15. McDonagh AF. The biliverdin-bilirubin antioxidant cycle of cellular protection: Missing a wheel? Free Radic Biol Med 2010; 49: 814-20.

  16. Bonkovsky HL, Lambrecht RW, Naishadham DN. Genetic variations in heme oxygenase-1 and chronic hepatitis. Hepatology 2010; 52: 401-402.




2020     |     www.medigraphic.com